Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cinacalcet for SHPT in pediatric CKD patients on dialysis
NCT01479088Phase 3
Key facts
- Status
- Unknown
- Start
- Mar 2010
- Primary completion
- Dec 2013
- Countries
- 1
- Drugs
- cinacalcet
- Conditions
- secondary hyperparathyroidism (SHPT)
01
Overview
Phase 3, open-label trial of cinacalcet in secondary hyperparathyroidism (SHPT). Status: unknown.
02
Design
- Study design
- Non-randomizedOpen-label
03
Registry description
Twelve-month, multicenter, intra-subject controlled (retrospective-prospective), open-label, active-treatment study to evaluate the dose-response and pharmacokinetics (PK) of cinacalcet HCl for the treatment of Secondary Hyperparathyroidism (SHPT) in paediatric subjects with chronic kidney disease (CKD) on dialysis, followed by 12-month study extension.
Beyond the preview
Go deeper on NCT01479088.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01479088.